Deerfield, Ill.-headquartered Walgreens Boots Alliance Inc. (WBA) continues to face pressure from pharmacy reimbursement, soft demand in the front-of-store, and elevated shrink, among other challenges. WBA's S&P Global Ratings-adjusted debt to EBITDA was 5.8x in 2024 and we now expect it will remain high above 5x well into 2026. Therefore, we lowered our long-term issuer rating to 'BB-' from 'BB' and our issue-level rating on the company?s senior unsecured debt to ?BB-? from ?BB?. We lowered our issue-level rating on the company's senior unsecured debt to 'BB-'. We also corrected an error in our recovery analysis to now include operating subsidiary Walgreen Co.?s opioid litigation settlement liability, which we believe is structurally senior to the debt issued by the parent.